Questions and Answers about Avastin | FDA - avastin fda not for breast cancer

Category

avastin fda not for breast cancer - FDA panel: Avastin not effective for breast cancer - Health - Cancer | NBC News


Jul 20, 2010 · FDA Panel: Avastin Not for Breast Cancer. That's the verdict of an FDA advisory panel, whose 12-1 vote urges the FDA to remove breast cancer from the list of approved uses of the Genentech drug. The vote is specific to breast cancer and does not affect Avastin's approval for the treatment of colon, lung, brain, or kidney cancer.Author: Daniel J. Denoon. Nov 19, 2011 · “This is the case with Avastin when used for the treatment of metastatic breast cancer.” Avastin will remain on the market as a treatment for other types of cancers Author: ANDREW POLLACK.

FDA is proposing that the breast cancer indication for Avastin be removed based on results from required clinical studies of the drug, including the AVADO and RIBBON1 studies, which established. That's the verdict of an FDA advisory panel, whose 12-1 vote urges the FDA to remove breast cancer from the list of approved uses of the Genentech drug. The vote is specific to breast cancer and does not affect Avastin's approval for the treatment of colon, lung, brain, or kidney cancer.

14 rows · FDA approval history for Avastin (bevacizumab) used to treat Colorectal Cancer, Non . Jun 29, 2011 · Avastin is FDA-approved for various types of colon, lung, kidney and brain cancer, which are not part of the debate. Doctors will still be allowed to prescribe Avastin for breast cancer.